Citation Impact
Citing Papers
Clinical review: the management of hypertensive crises.
2003
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
2008 Standout
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Comparative study of efficacy and safety of low-dose diltiazem or betaxolol in combination with digoxin to control ventricular rate in chronic atrial fibrillation: randomized crossover study
1995
Paraquat Poisonings: Mechanisms of Lung Toxicity, Clinical Features, and Treatment
2007 Standout
Descending control of pain
2002 Standout
Perindopril
1991
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
1992 Standout
Captopril
1988
Expert Committee Recommendations Regarding the Prevention, Assessment, and Treatment of Child and Adolescent Overweight and Obesity: Summary Report
2007 Standout
Psychedelics
2016 Standout
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A–deficient mice
2001 StandoutNobel
Pulse wave velocity as endpoint in large-scale intervention trial. The Complior® study
2001
Alpha‐adrenoceptors: A critical review
1989
Specific and sustained down-regulation of genes involved in fatty acid metabolism is not a hallmark of progression to cardiac failure in mice
2006
Age‐related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications
2003 Standout
Antiparkinsonian dopamine agonists: a review of the pharmacokinetics and neuropharmacology in animals and humans
1991
5-Hydroxytryptamine receptors in the human cardiovascular system
2006
Validity, Reproducibility, and Clinical Significance of Noninvasive Brachial-Ankle Pulse Wave Velocity Measurement.
2002 Standout
Measured Haplotype Analysis of the Angiotensin-I Converting Enzyme Gene
1998 StandoutNobel
Efficacy and safety ofdigoxin alone and in combination with low-dosediltiazem orbetaxolol to control ventricular rate in chronic atrial fibrillation
1995
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Comparative effects of ivabradine, a selective heart rate‐lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise
2005
Hydrogen sulphide and its therapeutic potential
2007 Standout
Turning Tumor-Promoting Copper into an Anti-Cancer Weapon via High-Throughput Chemistry
2010
Therapeutic Actions of Allylmercaptocaptopril and Captopril in a Rat Model of Metabolic Syndrome
2007
Expert consensus document on arterial stiffness: methodological issues and clinical applications
2006 Standout
Effect of long-term treatment with $beta;-blocker on cardiac hypertrophy in SHR
1989
Converting-Enzyme Inhibitors in the Treatment of Hypertension
1988
Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
1988 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Changes in Arterial Structure and Function Under Trandolapril-Verapamil Combination in Hypertension
1999
Tubuloglomerular feedback in ACE-deficient mice
1999 StandoutNobel
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
Pharmacological Approaches for the Treatment of Obesity
2002
Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension.
1988
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Pharmacological evidence for a role of ATP-dependent potassium channels in myocardial stunning.
1992
Systemic and regional hemodynamic profile of five angiotensin I converting enzyme inhibitors in the spontaneously hypertensive rat
1987
Overexpression of angiotensin AT 1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block
1997 StandoutNobel
Differential regulation of angiotensin peptide levels in plasma and kidney of the rat.
1991
Changes in renal angiotensin II receptors in spontaneously hypertensive rats by early treatment with the angiotensin-converting enzyme inhibitor captopril.
1994
Current and Potential Drugs for Treatment of Obesity
1999
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Angiotensin-Converting Enzyme Inhibitors
1998
Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat.
1982
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
The Metabolic Syndrome
2008 Standout
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Family history of subarachnoid haemorrhage: supplemental value of scrutinizing all relatives.
1997 Standout
Plasma angiotensins and blood pressure during converting enzyme inhibition.
1987
Reliability and Efficacy of Metoprolol and Diltiazem in Patients Having Mild to Moderate Mitral Stenosis with Sinus Rhythm
2002
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Smooth Muscle Cell Phenotypic Transition Associated With Calcification
2001 Standout
Works of C Richer being referenced
Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
1984
Survival, haemodynamics and cardiac remodelling follow up in mice after myocardial infarction
2003
Cardiovascular and biological effects of K+ channel openers, a class of drugs with vasorelaxant and cardioprotective properties
1990
Are vasopressin peripheral V1 receptors involved in the development of malignant hypertension and stroke in SHR‐SPs?
1995
Captopril and Hypertension Development in the SHR
1980
Influence of chronic renal failure on captopril pharmacokinetics and clinical and biological effects in hypertensive patients.
1984
β-Adrenoceptor Blockade and Genetic Hypertension Development in Rats
1980
?-Adrenoceptor blocking effects and plasma levels of bornaprolol and propranolol in man
1985
Captopril: pharmacokinetics, antihypertensive and biological effects in hypertensive patients.
1984
Attenuation by diltiazem of arterial baroreflex sensitivity in man
1984
Influence of captopril and enalapril on regional vascular alpha-adrenergic receptor reactivity in SHR.
1984
Perindopril, a New Converting Enzyme Inhibitor: Systemic and Regional Hemodynamics and Sympathoinhibitory Effects in Spontaneously Hypertensive Rats
1986
The effect of enalapril on baroreceptor mediated reflex function in normotensive subjects.
1985
Effects of captopril and enalapril on regional vascular resistance and reactivity in spontaneously hypertensive rats.
1983
Preliminary assessment of flutiorex, a new anorectic drug, in man.
1976
Beta‐adrenoceptor blocking effects and pharmacokinetics of betaxolol (SL 75212) in man.
1980
Perindopril, Converting Enzyme Blockade, and Peripheral Arterial Hemodynamics in the Healthy Volunteer
1987
Mechanism of action of ketanserin in hypertension
1986